NRBO READ THE FULL NRBO RESEARCH REPORT Business Update   Topline Results from Phase 2a Trial of DA-1241 in MASH Expected in ...

Turmeric is a natural herb that may affect how well other medications and supplements work. This includes cancer medications ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good morning. My name is Alan, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...

Ersodetug, a novel, fully human monoclonal antibody for the treatment of hyperinsulinism (HI), advancing in two late-stage, registrational ...

Total gross proceeds from upsized initial public offering and Series C financing were approximately $251.2 millionLast subject last visit in ...

XOMA Royalty recorded total income and revenues of $7.2 million for the third quarter of 2024, which included $6.5 million in estimated income associated with two commercial products in our portfolio.

Avexitide has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in three clinical ... The exploratory analyses on CSF biomarkers from participants ...

The patient had been suffering from hard-to-control diabetes despite intensive insulin treatment and had received a pancreas ...

Continuous glucose monitoring enhanced with geriatric principles was associated with reduced hypoglycemia in a cost-effective fashion.

There is no cure for autism—and, in fact, a "cure" isn't the goal of treatment. Autism is a type of neurodivergence, a way of being that differs from what society considers normal. It is characterized ...